Page last updated: 2024-08-22

1-hydroxypyrene and Affective Disorders

1-hydroxypyrene has been researched along with Affective Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, SI; Azzouz, N; Cather, C; Evins, AE; Foulds, J; Hameed, A; Hammett, E; Hrabovsky, S; Krebs, NM; Liao, J; Modesto, J; Muscat, JE; Pachas, GN; Richie, J; Veldheer, S; Yingst, J; Zhu, J	1

Trials

1 trial(s) available for 1-hydroxypyrene and Affective Disorders

Article	Year
A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. BMC public health, 2017, 01-19, Volume: 17, Issue:1 Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Method; Female; Humans; Male; Massachusetts; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Nitrosamines; Oxidative Stress; Pennsylvania; Pyrenes; Pyridines; Smoke; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration; Young Adult	2017

Article

Year

A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.

BMC public health, 2017, 01-19, Volume: 17, Issue:1

Topics: Adult; Anxiety Disorders; Biomarkers; Carbon Monoxide; Clinical Protocols; Cotinine; Double-Blind Method; Female; Humans; Male; Massachusetts; Mood Disorders; Nicotiana; Nicotine; Nicotinic Agonists; Nitrosamines; Oxidative Stress; Pennsylvania; Pyrenes; Pyridines; Smoke; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration; Young Adult

2017